VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer

Tutt, A. N. J.; Garber, J.; Gelber, R. D.; Phillips, K-A; Eisen, A.; Johannsson, O. T.; Rastogi, P.; Cui, K. Y.; Im, S-A; Yerushalmi, R.; Brufsky, A. M.; Taboada, M.; Rossi, G.; Yothers, G.; Singer, C.; Fein, L. E.; Loman, N.; Cameron, D.; Campbell, C.; Geyer, C. E.

doi:10.1016/j.annonc.2022.03.008

서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

S-Space

Publications

Detailed Information

VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer

Cited 12 time in Web of Science Cited 0 time in Scopus

Export

Authors: Tutt, A. N. J.; Garber, J.; Gelber, R. D.; Phillips, K-A; Eisen, A.; Johannsson, O. T.; Rastogi, P.; Cui, K. Y.; Im, S-A; Yerushalmi, R.; Brufsky, A. M.; Taboada, M.; Rossi, G.; Yothers, G.; Singer, C.; Fein, L. E.; Loman, N.; Cameron, D.; Campbell, C.; Geyer, C. E.